IRAK1 and idiopathic pulmonary fibrosis: We demonstrated that miR-146a-5p delivered through UC-sEvs produced anti-inflammatory and antifibrotic effects in two cell models and that it negatively regulated inflammation in IPF mouse tissues by targeting TRAF6/IRAK1.